Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF1344 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal Kallikrein 3/PSA Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects human KLK3 in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant human (rh) KLK2 is observed and less than 5% cross-reactivity with rhKLK1, rhKLK4, rhKLK5, rhKLK7, rhKLK8, rhKLK9, rhKLK10, rhKLK11, rhKLK12, rhKLK13, and rhKLK15 is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Anatomically-specific intratubular and interstitial biominerals in the human renal medullo-papillary complex.
Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection.
Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection.
Chen L, Hsi RS, Yang F, Sherer BA, Stoller ML, Ho SP
PloS one 2017;12(11):e0187103
PloS one 2017;12(11):e0187103
Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection.
Klyushnenkova EN, Kouiavskaia DV, Berard CA, Alexander RB
Journal of immunology (Baltimore, Md. : 1950) 2009 Feb 1;182(3):1242-6
Journal of immunology (Baltimore, Md. : 1950) 2009 Feb 1;182(3):1242-6
Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection.
Klyushnenkova EN, Kouiavskaia DV, Berard CA, Alexander RB
Journal of immunology (Baltimore, Md. : 1950) 2009 Feb 1;182(3):1242-6
Journal of immunology (Baltimore, Md. : 1950) 2009 Feb 1;182(3):1242-6
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Detection of Human Kallikrein 3/PSA by Western Blot. Detection of Human Kallikrein 3/PSA by Western Blot.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Detection of Human Kallikrein 3/PSA by Western Blot. Detection of Human Kallikrein 3/PSA by Western Blot.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Kallikrein 3/PSA in Human Kidney Cancer Tissue. Kallikrein 3/PSA in Human Kidney Cancer Tissue.
